732results about "Methine/polymethine dyes" patented technology

An optical filter includes: a substrate, an antireflection layer 1 including a dielectric multilayer film laminated on one main surface side of the substrate, and an antireflection layer 2 including a dielectric multilayer film laminated on the other main surface side of the substrate. The substrate includes a near-infrared ray absorbing glass and a resin film, the resin film includes a resin, a UV dye having a maximum absorption wavelength in 350 nm to 410 nm in the resin, and an IR dye having a maximum absorption wavelength in 700 nm to 850 nm in the resin, and the optical filter satisfies all of the characteristics (i-1) to (i-7).

The present invention discloses a preparation method of yellow azoxy and azo stilbene dyes. Using 4-nitrotoluene-2-sulfonic acid as a raw material and water as a reaction solvent, in the presence of choline hydroxide, dye yellow 11 is obtained through a condensation reaction. The molecular structure of choline hydroxide contains a quaternary ammonium salt group and a hydroxyl group. The hydroxyl group provides additional hydrophilicity, which helps to improve the solubility and dispersibility of the dye in an aqueous medium and enhance the affinity between the dye and the fiber. Choline hydroxide can effectively provide the alkaline environment required for the reaction, promote the synthesis reaction of the dye, and better control the selectivity and yield of the reaction. Since the choline hydroxide molecule contains a hydroxyl group, it can form hydrogen bonds with the sulfonic acid groups in the dye molecule, enhance the stability between dye molecules, and improve the light fastness and acid and alkali resistance of the dye. Using choline hydroxide not only optimizes the reaction conditions, improves the purity and yield of the dye, but also significantly improves the performance of dye yellow 11.

The invention relates to the field of biomedicine, particularly provides a copper-based nano-enzyme as well as a preparation method and application thereof, and aims to solve the problems that in the prior art, clinical treatment on primary sclerosing cholangitis (PSC) is difficult in diagnosis and lacks of effective treatment drugs. The copper-based nano-enzyme comprises a nano-enzyme carrier and a copper-based nano-enzyme, wherein the nano-enzyme carrier is a two-dimensional nanosheet formed by copper ions, gallic acid and ursodesoxycholic acid through coordinate bonds; the probe molecule is a cyanine dye molecule connected to the surface of the nano-enzyme carrier through a covalent bond; wherein the fluorescence intensity of the copper-based nano enzyme is enhanced after the action of the alkaline phosphatase. The three functions of alkaline phosphatase responsive diagnosis, nano-enzyme catalytic treatment and ursodesoxycholic acid hepatic targeting are innovatively and synergistically integrated into one nano platform, the treatment function can be executed while specific imaging diagnosis is performed on diseases, and a new strategy is provided for diagnosis and treatment of diseases such as PSC.

The present disclosure is directed, in general, to (1) nonlinear optical (NLO) chromophores containing spirofluorene-isophorone bridging groups, including (2) compositions / materials / resistive layers comprising NLO chromophores containing spirofluorene-isophorone bridging groups, and the methods of making the compositions / materials / resistive layers comprising NLO chromophores containing spirofluorene-isophorone bridging groups (e.g., methods of poling and / or drying, and the like), (3) uses of NLO chromophores containing spirofluorene-isophorone bridging groups in electro-optic devices (e.g., EOMs).

The invention belongs to the technical field of near-infrared organic dye synthesis, and particularly discloses a cyanine dye with J aggregation characteristic, J aggregation nanoparticles, and preparation methods and applications of the cyanine dye and the J aggregation nanoparticles. The cyanine dye is 1-ethyl-2-(2-(2-(-3-(2-(1-ethyl-3, 3-dimethyl-1, 3-dihydro-2H-benzo [g] indole-2-subunit) ethylidene)-2-(2, 2, 2-trifluoro-N-(2-methylbenzyl) acetamide) cyclopent-1-ene-1-yl) vinyl)-3, 3-dimethyl-3H-benzo [g] indoleiodised salt, and the structural formula of the cyanine dye is shown in the description. The preparation method is simple, the J aggregation nanoparticles can be prepared by utilizing the unique property of J aggregation, the J aggregation nanoparticles have high light stability and have strong fluorescence emission in a near-infrared second region, and the material prepared by the invention can be used as a contrast agent and is applied to the field of near-infrared second region fluorescence imaging.

Hydrogels that degrade under appropriate conditions of pH and temperature by virtue of crosslinking compounds that cleave through an elimination reaction are described. The hydrogels may be used for delivery of various agents, such as pharmaceuticals.

The invention relates to a fluorescent whitening agent, in particular to a stilbene biphenyl fluorescent whitening agent and a preparation method thereof. The stilbene biphenyl fluorescent whitening agent is a crystal represented by a formula (1), and contains crystal water or an isomer. The fluorescent whitening agent CBS provided by the invention comprises rod-shaped, needle-shaped and lamellar crystal forms. In the invention, all crystal forms are measured by adopting an X-ray diffractometer, and the water content is precisely measured by adopting a KarlFischer titration method. The X-ray scanning spectrum peak attributions of the crystal samples obtained by different preparation methods have significant difference. # imgabs0 #

Electrically neutral complex compounds of formula I including any stereoisomer or E / Z isomer thereof wherein: M is Fe < 2 + >, Ru < 2 + >, Os < 2 + >, Co < 3 + >, Rh < 2 + >, Rh < 3 + >, Ir < 3 + >, Ni < 2 + >, Pd < 2 + >, Pt < 2 + > or Pt < 4 + >, in particular Ru < 2 + >; t and T'are H or (C1-C3)-alkyl; lig is a bidentate ligand, in particular 2, 2 '-dipyridyl (bpy) or 4, 7-diphenyl-1, 10-phenanthroline (BPhen); and A is an anion from a pharmaceutically acceptable acid, the electrically neutral complex compounds of formula I are useful in human therapy, in particular as photosensitizers (PS) in photodynamic therapy (PDT) of cancer, skin diseases, fungal infections or microbial infections. They are almost non-toxic under dark conditions at therapeutic doses and exhibit good to excellent photoactivity under hypoxic conditions. They can be used for PDT treatment of deep hypoxia tumors by using light within a far-infrared to near-infrared light treatment window.

A cat litter comprising an absorbent and at least one fluorescent compound wherein the at least one fluorescent compound does not include cat urine wherein the at least one fluorescent compound attracts a cat to excrete in the cat litter. The cat litter comprises a solid particulate material coated with a cellulose solution comprising at least one fluorescent material.

The invention is applicable to the technical field of near-infrared imaging probes, and provides a near-infrared two-region albumin efficient in-situ targeting cyanine dye as well as a preparation method and application thereof. The structural formula of the cyanine dye is # imgabs 0 #, R structure is I or II: # imgabs 1 #, and n is any one of 2-10. The cyanine dye provided by the invention can quickly form stable covalent binding with albumin in situ in an in-vitro or in-vivo physiological environment so as to generate bionic fluorescent protein with bright luminescence and high biocompatibility. The in-situ bionic fluorescent protein construction strategy provided by the invention not only can realize high-resolution mouse angiography, but also can realize real-time and accurate monitoring on blood-brain barrier damage accompanying cerebral ischemic stroke of the mouse. The dye provided by the invention can realize multi-channel joint monitoring with angiographic contrast agents with different excitation wavelengths, and realizes simultaneous marking of cerebral vascular and brain injury after cerebral apoplexy.

Provided herein are methods for multiplexed in situ analysis of biomolecules in a tissue. In particular, provided herein are methods for multiplexed single-cell in situ protein and nucleic acid profiling in fixed or fresh tissues, that allows the investigation of the different cell compositions and their spatial organizations in intact tissues through consecutive cycles of probe hybridization, fluorescence imaging, and signal removal.

The invention belongs to the technical field of biochemistry, and relates to a fluorescence / photoacoustic bimodal probe responding to Cu (I) and a preparation method and application thereof. The fluorescence / photoacoustic bimodal probe responding to Cu (I) has high selectivity and sensitivity, has efficient tumor targeting ability, can be used for dynamic tracing of Cu (I) in tumor, can dynamically image Cu (I) in tumor by combining with a three-dimensional photoacoustic / living body fluorescence imaging technology and the probe HCyCu1, provides a new detection means for detection of Cu (I), and has wide application prospects. And a potential tool is provided for tumor diagnosis. According to the preparation method of the bimodal probe, the adopted raw materials are easy to obtain, the reaction conditions are mild and easy to control, the reaction cost is saved, and the yield of a target product is guaranteed. The structural formula of the probe is as follows: # imgabs0 #.

The invention discloses a multi-cyano offset substituted pentamethine cyanine dye and a synthesis method and application thereof, and the dye has the following general formula structure: # imgabs0. According to the multi-cyano offset substituted pentamethine cyanine dye disclosed by the invention, the absorption emission wavelength is increased by introducing an offset substitution structure; the dye has near-infrared first-area imaging and treatment performance, so that the optimal excitation and emission wavelength can be flexibly selected, the dye shows obvious Stokes shift, reduction of self-absorption and scattering effects is facilitated, the imaging definition and depth are improved, the molar extinction coefficient of the prepared dye is up to 190000, and the dye can be applied to near-infrared first-area imaging and treatment of the near-infrared first-area imaging and treatment of the near-infrared first-area imaging and treatment of the near-infrared first-area imaging. According to the present invention, with the application of the dye, the light energy utilization degree of the dye is substantially improved, the long wavelength light with the deeper penetration depth can be strongly absorbed, the light energy capture and conversion can be effectively achieved, the photosensitizer efficiency can be improved, the light dose can be reduced, the phototoxicity can be reduced, the high absolute fluorescence quantum yield can be represented, and the biological imaging effect can be substantially improved; and the imaging quality is higher.

The invention discloses a fluorine-substituted pentamethine cyanine dye and a preparation method and application thereof, the fluorine-substituted pentamethine cyanine dye has a structure shown in a general formula I: # imgabs0 #, and by introducing fluorine atoms to an indole benzene ring and introducing different groups to an N site, accurate regulation and control of light stability of dye molecules are realized. The fluorine-substituted pentamethine cyanine dye prepared by the invention shows remarkable advantages in spectral characteristics, has a molar extinction coefficient higher than that of the traditional cyanine dye and has strong light energy absorption capacity, and is beneficial to improving the light energy utilization rate and reducing the dye dosage; the absolute fluorescence quantum yield reaches a high level, the intensity and sensitivity of imaging signals are remarkably enhanced, and a more sensitive and reliable tool is provided for biological imaging and molecular detection.

The invention discloses a triarylmethane type I photosensitive dye as well as a synthesis method and application thereof. The structure of the dye is shown as a general formula I; intramolecular charge separation is optimized by regulating substituent groups, and the generation efficiency of superoxide anions and hydroxyl radicals is remarkably improved. According to the synthesis method, 4-diphenylaminobenzaldehyde or 4-vinyl benzaldehyde is used as a raw material, efficient preparation is achieved through the steps of condensation, oxidation and the like, the raw material is easy to obtain, and operation is easy and convenient. The dye has strong absorption at the wavelength of 600-630 nm, is suitable for red light triggered photodynamic therapy (PDT), especially keeps high reactive oxygen yield under the hypoxic condition, and breaks through the oxygen dependence limitation of traditional PDT. Experiments show that the dye can induce ferroptosis of tumor cells, has the functions of fluorescence imaging and treatment, and has wide application prospects in the fields of antitumor drugs, in-vivo fluorescence labeling, photoresponsive functional preparations and the like.

The invention provides a series of cyanine or cyanine-like multifunctional probe molecules which are derivatives with a near-infrared cyanine dye molecular skeleton, and the skeleton is modified with any one or a combination of more than two of a protein affinity agent structure, a targeting group or a functional group; the near-infrared cyanine dye molecule is a near-infrared indole cyanine dye molecule or a near-infrared naphthopyrrole cyanine or flavonoid dye molecule; the structure of the protein affinity agent is from a 4 (p-iodophenyl) butyric acid derivative, Evans blue or a derivative thereof; the targeting group is a structure containing any one pharmaceutically acceptable targeting peptide; the functional group comes from any nuclide chelating agent or a functional drug molecule with a modification site. The multifunctional probe molecule provided by the invention can realize clear near-infrared first-region and second-region lymphatic imaging and angiography, and has good biological safety and adjustable circulation metabolism time at the same time. The invention also provides a method for preparing the multifunctional probe molecule and application of the multifunctional probe molecule in multi-mode diagnosis and treatment.

The present invention discloses an anthraquinone and anthracene compound meso-substituted cyanine dye, its preparation method, and application. The anthraquinone and anthracene compound meso-substituted cyanine dye is prepared by meso-substituting a heptamethine cyanine dye with an anthraquinone or anthracene compound. The substituent groups regulate the fluorescence emission and heat release pathways of the dye, enhancing the photothermal effect of the dye molecule and enabling photoacoustic imaging. Furthermore, its excellent biocompatibility and low cytotoxicity make it suitable for use in the biological and medical fields.

The invention discloses a preparation method and application of near-infrared fluorescent dye DOM-O for acute alcoholic liver injury detection. The specific chemical structural formula of the near-infrared fluorescent dye DOM-O is shown in the specification. The near-infrared fluorescent dye prepared by the invention has excellent fluorescence imaging performance, can realize specific fluorescence imaging diagnosis of the acute alcoholic liver injury, and provides an imaging dye with application prospect for early detection and clinical diagnosis of the acute alcoholic liver injury.

The present invention relates to precursors of dibenzoylmethane compounds having an amide group on one of the rings, and corresponding photoconversion compounds, pharmaceutically or cosmetically acceptable salts thereof, or stereoisomers or mixtures thereof, for use in protecting human or animal living organisms or materials from ultraviolet light. The present invention also relates to the preparation processes thereof, as well as cosmetic compositions, pharmaceutical compositions or personal care compositions thereof.

The application relates to an electronic device comprising an anode, a cathode, at least one emitting layer between the anode and the cathode, at least one p-doped layer A containing a mono-triarylamine as a host, and at least one layer B containing a mono-triarylamine. The invention further relates to a p-doped mixture comprising a mono-triarylamine of formula (II), (III) or (IV) as a host and an electron acceptor compound as a dopant, and the use of the mixture in an electronic device.

A wavelength selective absorption filter contains a resin, a coloring agent, and a compound having at least one polar group of a carboxylic acid ester bond, a carboxylic acid amide bond, a sulfonic acid amide bond, a urethane bond, or a sulfonyl bond and a MW≤1,000 where dye includes at least one of dye A having a main absorption wavelength range at a wavelength of 390 to 440 nm and dye D having a main absorption wavelength range at a wavelength of 680 to 780 nm, a 20% value wavelength A with respect to an absorbance maximal value exhibited by a main absorption wavelength is 455 nm or less where dye A is contained, and a 20% value wavelength D with respect to the absorbance maximal value exhibited by the main absorption wavelength is 640 nm or more where dye D is contained, and a display device.

A heptamethine cyanine near-infrared fluorescent dye as well as a preparation method and use thereof are provided, and relate to the technical field of organic fluorescent molecules. The heptamethine cyanine near-infrared fluorescent dye has a structure represented by formula I. The heptamethine cyanine near-infrared fluorescent dye provided in the present disclosure has better in-vivo metabolic characteristics, no accumulation in normal tissues such as liver and long tumor tissue developing window time, is more suitable for precise diagnosis of tumors, possesses a certain clinical application prospect, and can be applied to fluorography of clinical tumors and the like.

This invention relates to compounds and methods for treating cancer. In various embodiments, the compound includes a heptamethine carbocyanine dye (HMCD) component, a camptothecin derivative component, and a linker moiety (L) connecting the HMCD component and the camptothecin derivative component. In various embodiments, the method includes administering a therapeutically effective amount of the compound to a subject, thereby contacting a tissue of the subject with the compound such that the compound binds to the tissue; detecting the compound bound to the tissue, wherein the presence of the compound bound to the tissue is indicative of the cancer in the subject; and delivering the compound to the tissue thereby treating the cancer in the subject.

The present disclosure relates to a novel fluorogenic dimer compound, useful as a probe for detection of endogenous receptors, in particular G protein-coupled receptors. The present invention provides compositions and kits comprising such compound and methods of labeling a biomolecule, comprising the step of contacting the biomolecule with the compound of the invention.

The invention belongs to the field of biosensing and fluorescence imaging, and particularly relates to a fluorescent probe compound and application thereof. The probe compound is a compound as shown in a formula I or a compound as shown in a formula II, or a pharmaceutically acceptable salt thereof; the structures of the compound in the formula I and the compound in the formula II are shown in the specification, and the definition of each group is shown in any embodiment of the invention. The fluorescent probe compound shows rapid and high reactivity to oxidizing free radicals, the generated fluorescent compound is high in fluorescence intensity and good in stability, and early diagnosis can be carried out on ferroptosis-related disease models such as oxygen-glucose deprivation / reperfusion and drug liver injury on living cell or living body levels and the like. I II

The present invention relates to the technical field of organic functional materials, and particularly relates to a D-π-A type semi-cyanine dye, a preparation method and an application thereof. The D-π-A type semi-cyanine dye uses a benzopyran derivative part as a donor and a semi-cyanine dye part as an acceptor, and a π-bridge with different conjugation degrees is introduced between the semi-cyanine dye and the benzopyran derivative. The synthesized compound has good photostability, good photothermal imaging properties, the fluorescence emission wavelength reaches the second near-infrared region, the Stokes shift can reach up to 157 nm at most, and has good biocompatibility, and can be used for cell imaging and small animal in vivo imaging; and can rapidly rise from 30 °C to 53 °C within 2 minutes and reach a steady state at about 56 °C, and has excellent photothermal therapy effect, and has great potential application prospects in the field of tumor treatment.

The present disclosure is directed, in general, to (1) nonlinear optical (NLO) chromophores containing furanyl accepting groups, including (2) compositions / materials / resistive layers comprising NLO chromophores containing furanyl accepting groups, and the methods of making the compositions / materials / resistive layers comprising NLO chromophores containing furanyl accepting groups (e.g., methods of drying and / or poling, and the like), (3) uses of NLO chromophores containing furanyl accepting groups in electro-optic devices (e.g., EOMs).

The present invention provides a grease-responsive color-changing fluorescent dye, which is synthesized using 4-formyltriphenylamine and an indone compound as raw materials. The structure of the fluorescent dye is different from that of existing fluorescent dyes, and the fluorescent dye is a novel grease-responsive fluorescent dye. The preparation method provided by the present invention is simple, the product yield is high, the stability is good, and the biological toxicity is low. When applied to fluorescent fingerprint powder, the fluorescent dye can respond to latent fingerprints and cause color change, changing the orange-red fluorescent color of the fluorescent fingerprint powder itself to bright yellow fluorescent color. Therefore, compared with other fluorescent dyes, the fluorescent dye has higher contrast, anti-interference and biocompatibility, can achieve imaging effects with high resolution, high contrast, strong anti-interference and real-time development, and has broad application prospects in latent fingerprint recognition in complex criminal investigation environments.

The present invention relates to the field of optical imaging. More particularly, it relates to compounds of the cyanine family with near-infrared emission characterized by improved physico-chemical and biological properties and to conjugates with biological ligands thereof. The invention also relates to the use of these compounds as optical diagnostic agents in imaging or therapy of solid tumors, to the methods for their preparation and to the compositions comprising them.